Efficacy and Safety of Tumour Necrosis Factor-α Antagonists for Folliculitis Decalvans: A Retrospective Case-series Pilot Study

Efficacy and Safety of Tumour Necrosis Factor-α Antagonists for Folliculitis Decalvans: A Retrospective Case-series Pilot Study

Folliculitis decalvans is a chronic inflammatory skin disease leading to scarring alopecia. Management of this disabling disease is difficult and no treatment is currently approved. Current knowledge regarding the pathogenesis of folliculitis decalvans suggests the benefit of using anti-tumour necro...

Full description

Bibliographic Details
Main Authors: Aurore Dupont, Alexia Eyraud, Brigitte Milpied, Sylvie de Bataille, Eline Cassassa, Anne-Sophie Darrigade, Thomas Barnetche, Marie-Sylvie Doutre, Bruno Matard, Marie Beylot-Barry, Julien Seneschal
Format: Article
Language:English
Published: Medical Journals Sweden 2023-03-01
Series:Acta Dermato-Venereologica
Subjects:
folliculitis decalvans
infliximab
adalimumab
TNFα inhibitor
cicatricial alopecia
Online Access:https://medicaljournalssweden.se/actadv/article/view/3713

Internet

https://medicaljournalssweden.se/actadv/article/view/3713

Similar Items